13F Portfolios

Saturn V Capital Management LP: X4 PHARMACEUTICALS INC (XFOR): Quarterly 13F Position History

As of Q1 2026, Saturn V Capital Management LP reported 6,456,646 shares of X4 PHARMACEUTICALS INC (XFOR), worth $26.7M and representing 4.8% of its 13F equity book. Quarter-over-quarter share count change: + 656,116 (+11.3%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: Saturn V Capital Management LP first reported XFOR on the Q4 2025 filing — fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 6,456,646 +656,116 +11.3% $26.7M 4.8% $4.1
Q4 2025 5,800,530 $23.2M 4.3% $4.0

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Saturn V Capital Management LP first disclose a XFOR position in 13F-HR filings?

Saturn V Capital Management LP first reported X4 PHARMACEUTICALS INC (XFOR) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Saturn V Capital Management LP's most recent quarter-over-quarter share-count change in XFOR?

Between Q4 2025 and Q1 2026, Saturn V Capital Management LP added 656,116 shares of XFOR (+11.3%), bringing the total reported position to 6,456,646 shares at a market value of $26.7M.

Does the implied price-per-share represent Saturn V Capital Management LP's cost basis in XFOR?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.